Tobi Guennel, Ph.D, is Vice President and Chief Architect, and Renee Deehan-Kenney, Ph.D, is Vice President of Computational Biology, both at QuartzBio, part of Precision for Medicine.
With public data set to play an increasingly important role in drug discovery and development, an integrated, data-driven approach to clinical planning can optimize the probability of success.